Tetra Pharm Technologies

BiotechnologySeries ACopenhagen, Denmarktetra-pharm.com

Latest round

Series A

Last raised

Jan 2023

Total raised

$9.8M

Investors

5

About Tetra Pharm Technologies

Based in Copenhagen, Denmark, and founded in 2018, Tetra Pharm Technologies ApS operates as a research-focused biopharmaceutical company delivering cannabinoid-based therapies. As of January 2023, Martin Rose serves as the CEO of the company. The company offers therapeutic development for the ECS, GMP manufacture of commercial pharmaceuticals, and CDMO services and partnerships. The firm's objectives include researching potential new drugs, creating, and perfecting fresh drug formulations, conducting clinical studies, and commercialising drugs that target the endocannabinoid system.

Who invested in Tetra Pharm Technologies

5 investors across 1 round

See all investors in Tetra Pharm Technologies

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jan 26, 2023

    Amount

    $9.8M

    Investors

    Locked

Questions about Tetra Pharm Technologies

Who invested in Tetra Pharm Technologies?

Tetra Pharm Technologies has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Tetra Pharm Technologies raised?

Tetra Pharm Technologies has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Tetra Pharm Technologies last raise money?

Tetra Pharm Technologies's most recent round on record is a Series A, in Jan 2023.

What does Tetra Pharm Technologies do?

Based in Copenhagen, Denmark, and founded in 2018, Tetra Pharm Technologies ApS operates as a research-focused biopharmaceutical company delivering cannabinoid-based therapies.

Where is Tetra Pharm Technologies headquartered?

Tetra Pharm Technologies is headquartered in Copenhagen, Denmark.

Which VCs invest in companies like Tetra Pharm Technologies?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Tetra Pharm Technologies's stage. Their profiles are linked below.

Raising like Tetra Pharm Technologies? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.